SENS · Senseonics Holdings, Inc.
$10.24
+0.36 (+3.59%)
At close · Oct 5
Return incl. dividend (before tax)
Market Cap
$528.74M
Shares
52.87M
Volume · Oct 5
387.1K
Avg daily vol (3M)
678.23K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$9.88
Open$10.04
Day$9.78–10.09
52W close$4.86–11.30
Avg vol 30d702K
Short int5.1M · 9.6% float · 8.5d
Short vol58%
Last earningsAug 6, 2026
DataJan 2020–Oct 2026
Filing10-Q · Aug 6
Up next
Next earnings call
Nov 5, 2026
Est · unconfirmed
· in 4 wks
filed Aug 6, 2026
call held Aug 6, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
9.6%
Latest settlement · 8.5 days to cover
Equibles Rating
blended score · not investment adviceOverall
Buy
SellHoldBuy
Technical
Buy
Momentum
Very Strong
Sentiment
Bullish
Fundamentals
Excellent
Quant / Vol
Very High
Market backdrop
VIX 15.3 · calm
Equity put/call 0.58
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+42%
above
Price vs 50-day avg
+18%
above
RSI (14)
59
neutral
MACD trend
Negative
52-week position
78%
mid-range
Momentum
relative strength
1-month return
0%
trailing
6-month return
+47%
trailing
YTD return
+79%
this year
Relative strength
+35%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $8 › 200d $7 — 50d above 200d
Institutional flow
Accumulating
+24% holders QoQ · +42 funds added
Insider flow
Accumulating
Net +$125.3K over 90 days · 0% sells
Short interest
Falling
9.56% of float · ▼ -3.0% MoM · 8.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
110 holders — mid 3-yr range
Squeeze score
81
high risk · 0–100
Fundamentals
Revenue growth
+20%
Y/Y
Gross margin
96%
expanding
EPS growth
+34%
Y/Y
Balance sheet
$4.6M
net cash
Quant / Vol
risk profile
Volatility
84%
annualized · 1-yr
Max drawdown
−57%
past year
ATR
4.8%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Latest guidance
· from the 8-K filed Aug 6, 2026
Global net revenue
· full-year 2026
Initiated
$62M – $66M
prior FY $35.26M
midpoint +81.5% Y/Y
Gross margin
· full-year 2026
Initiated
58% – 61%
Guided vs delivered
· last 5 settled
Global net revenue
Full Year 2024
guided $22M – $24M
$22.47M
In line
Global net revenue
full year 2023
guided $20M – $24M
$22.39M
In line
Global net revenue
2021
guided $12M – $15M
$13.68M
In line
Global net revenue
fourth quarter
guided $2.5M
$4.95M
Beat +98.0%
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+42%
Bullish
Price vs 50-day avg
+18%
Bullish
RSI (14)
59
Neutral
MACD trend
Negative
Bearish
52-week position
78%
Neutral
Market signals — smart money & positioning
Bullish · 3 of 6
Trend (MA cross)
No cross
50d $8 › 200d $7 — 50d above 200d
Institutional flow
Accumulating
+24% holders QoQ · +42 funds added
Insider flow
Accumulating
Net +$125.3K over 90 days · 0% sells
Short interest
Falling
9.56% of float · ▼ -3.0% MoM · 8.5 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
110 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $5
Now $10 · 78%
Range high $11
vs 200-day avg +42%
vs 50-day avg +18%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Capital raised during Q2 | $100M | Q2 2026 | — |
| Eon Care nurses | 90 | Q2 2026 | — |
| Equity proceeds raised in Q2 | $90M | Q2 2026 | — |
| Expanded Hercules Capital facility capacity | $140M | Q2 2026 | — |
| Share of Eversense insertion procedures via Eon Care | 40% | Q2 2026 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SENS
this stock
Senseonics Holdings, Inc.
|
$528.74M | +79.0% | +19.8% | — | 9.6% |
|
ABT
Abbott Laboratories
|
$174.90B | -22.2% | +5.7% | 28.1 | 1.1% |
|
MDT
Medtronic plc
|
$113.38B | -10.1% | +8.4% | 21.8 | 1.3% |
|
SYK
Stryker Corp
|
$104.47B | -21.6% | +11.2% | 28.2 | 2.0% |
|
BSX
Boston Scientific Corp
|
$63.59B | -55.3% | +12.5% | 17.8 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SENS | -1.2% | -0.2% | +47.0% | -2.9% | +79.0% |
| SPY | -0.2% | -0.5% | +12.2% | +0.9% | +12.9% |
| vs SPY | -1.0% | +0.3% | +34.8% | -3.8% | +66.1% |